Two ways to partner with Irifar.
Irifar sits at the centre of the journey an innovative medicine takes to reach new markets. We partner in two directions: with the originator and innovator companies whose products we in-license, and with the distributors through whom we bring those products to patients.
For originators & licensors
Bring your medicine to new markets
Originator and innovator companies looking to extend a branded medicine into Asia, the Middle East, Africa and Eastern Europe without building local infrastructure.
Read more ↓For distributors & trade partners
Add innovative medicines to your portfolio
National and regional distributors, importers and trade partners seeking innovative, branded originator products that are registered and ready for their market.
Read more ↓01
Bring your medicine to new markets
If you are an originator or innovator company with a branded medicine and you want to extend its reach into international markets without building local infrastructure, Irifar is your partner. We in-license your product and take responsibility for its registration, marketing, promotion and distribution, protecting your brand and your standards throughout.
What we offer originators
- Expert in-licensing and a single, accountable partner
- Regulatory registration and market access in target territories
- Professional marketing and promotion of your brand
- Access to an established global distributor network
- Careful stewardship of your product's reputation and lifecycle
02
Add innovative medicines to your portfolio
If you are a distributor seeking access to innovative, branded originator products, Irifar offers a growing portfolio across high-value specialty and hospital therapeutic areas. We provide the products, the registrations and the marketing support; you provide the local market reach.
What we offer distributors
- A portfolio of innovative, branded originator products
- Products registered and ready for your market
- Marketing and promotional support
- Coverage across pain management, anti-infectives, oncology, haematology and critical care
- A reliable, long-term supply partnership
One accountable partner, from licence to patient.
03
Our model: how it works
Every product we bring to market follows the same five stages.
- 01
In-licensing
We secure the rights to innovative originator products from the companies that develop them.
- 02
Registration & market access
We obtain the marketing authorisations and registrations required in each territory.
- 03
Marketing & promotion
We build and execute the marketing and promotional strategy for each brand.
- 04
Global distribution
We bring products to patients through a network of established local distributors.
- 05
Lifecycle & compliance
We maintain authorisations and uphold pharmacovigilance and quality obligations throughout the product's life.
04
Partnership models we offer
The agreement shape follows the relationship. Most partnerships combine two of these.
-
Exclusive in-licensing
Exclusive in-licensing agreements for innovative originator products entering new markets.
-
Territory-based distribution
Territory-based distribution agreements giving distributors access to our portfolio.
-
Marketing & promotion
Marketing and promotion partnerships building demand for innovative brands.
-
Long-term supply
Long-term supply partnerships structured around reliability and growth.
05
Our partnering process
From first contact to ongoing stewardship, the steps are the same whether you are an originator or a distributor.
- 01
Initial contact & confidentiality
We discuss the opportunity under NDA.
- 02
Evaluation & fit
We assess the product or market against our focus and network.
- 03
Proposal & agreement
We define territory, model and commercial terms.
- 04
Registration & launch
We register the product and prepare it for market.
- 05
Marketing, promotion & distribution
We build demand and deliver through local distributors.
- 06
Ongoing stewardship
Lifecycle, compliance and performance management.
Ready to partner?
Whether you are an originator or a distributor, start a conversation with our business development team.